Leptin and endothelin-1 mediated increased extracellular matrix protein production and cardiomyocyte hypertrophy in diabetic heart diseas

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 5, 2009, Pages 452-463

  Majumdar, Pijush ^a   Chen, Shali ^a   George, Biju ^a   Sen, Subhrojit ^a   Karmazyn, Morris ^a   Chakrabarti, Subrata ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Diabetic cardiomyopathy; Endothelin 1; Fibronectin; Leptin

Indexed keywords

BOSENTAN; ENDOTHELIN 1; FIBRONECTIN; GLUCOSE; LEPTIN; MESSENGER RNA; LEPTIN RECEPTOR; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENDOTHELIUM CELL; GENE EXPRESSION; HEART MUSCLE CELL; HORMONE ACTION; HUMAN; HUMAN CELL; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; RAT; STREPTOZOCIN DIABETES; UMBILICAL VEIN; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CYTOLOGY; DIABETIC ANGIOPATHY; GENETICS; HYPERTROPHY; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; ENDOTHELIN-1; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HUMANS; HYPERTROPHY; LEPTIN; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LEPTIN; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; UMBILICAL VEINS;

EID: 70350662888     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.964     Document Type: Article

References (46)

1. Raman M, Nesto RW. Heart disease in diabetes mellitus. Endocrinol Metab Clin North Am 1996; 25: 425-438.
2. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 2004; 107: 539-557. (Pubitemid 39627201)
3. Bell DS. Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease?. Diabetes Care 1995; 18: 708-714.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820. (Pubitemid 34000785)
5. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002; 288: 2579-2588.
6. Levin ER. Endothelins. N Eng J Med 1995; 333: 356-363.
7. Chen S, Khan ZA, Karmazyn M, Chakrabarti S. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Diabetes Metab Res Rev 2007; 23: 356-367. (Pubitemid 47091238)
8. Khan ZA, Farhanghoee H, Mahon JL, et al. Endothelins: regulators of extracellular matrix protein production in diabetes. Exp Biol Med 2006; 231: 1022-1029. Maywood).
9. Gulen S, Dincer S. Effects of leptin on oxidative stress in healthy and streptozotocin-induced diabetic rats. Mol Cell Biochem 2007; 302: 59-65. (Pubitemid 47202321)
10. Kimura K, Tsuda K, Baba A, et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 2000; 273: 745-749. (Pubitemid 30599054)
11. Purdham DM, Zou MX, Rajapurohitam V, Karmazyn M. Rat heart is a site of leptin production and action. Am J Physiol 2004; 287: H2877-H2884. (Pubitemid 39557163)
12. Bjorbaek C, Uotani S, Da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997; 272: 32686-32695. (Pubitemid 28011961)
13. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999; 13: 1231-1238. (Pubitemid 29300368)
14. Lembo G, Vecchione C, Fratta L, et al. Leptin induces direct vasodilation through distinct endothelial mechanism. Diabetes 2000; 49: 293-297. (Pubitemid 30071008)
15. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003; 93: 277-279. (Pubitemid 37048239)
16. Xu F, Chen M, Wang Y, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004; 110: 1269-1275. (Pubitemid 39202344)
17. Han DC, Isono M, Chen S, et al. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGFbeta type II receptor expression. Kidney Int 2001; 59: 1315-1323. (Pubitemid 32281219)
18. Khan ZA, Caurtero J, Barbin YP, Chan BM, Uniyal S, Chakrabarti S. ED-B fibronectin in non-small cell lung carcinoma. Exp Lung Res 2005; 31: 701-711. (Pubitemid 41359310)
19. Chen S, Khan Z, Cukiernik M, Chakrabarti S. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab 2003; 284: E1089-E1097. (Pubitemid 36617453)
20. Feng B, Chen S, Chiu J, George B, Chakrabarti S. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab 2008; 294: E1119-E1126.
21. Zeidan A, Purdham DM, Rajapurohitam V, Javadov S, Chakrabarti S, Karmazyn M. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy. J Pharmacol Exp Ther 2005; 315: 1075-1084. (Pubitemid 41635393)
22. Evans T, Deng DX, Chen S, Chakrabarti S. Endothelin receptor blockade prevents extracellular matrix component mRNA expression and capillary basement thickening in the retina of diabetic and galactose-fed rats. Diabetes 2008; 49: 662-666.
23. Peelman F, Van Beneden K, Zabeau L, et al. Mapping of the leptin binding sites and design of a leptin antagonist. J Biol Chem 2005; 279: 41038-41046. (Pubitemid 39287705)
24. Niv-Spector L, Gonen-Berger D, Gourdou I, et al. Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem J 2005; 391: 221-230. (Pubitemid 41532418)
25. Hileeto D, Cukiernik M, Mukherjee S, et al. Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium. Diabetes Metab Res Rev 2002; 18: 386-394. (Pubitemid 35256595)
26. Weigert C, Brodbeck K, Brosius III FC, et al. Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes 2003; 52: 527-535. (Pubitemid 36173213)
27. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In Diabetes in America, Harris MI (ed). National Health Institute (Publication 95-1468): Bethesda, 1995; 233-257.
28. Feuvray D, Darmellah A. Diabetes-related metabolic perturbations in cardiac myocyte. Diabetes Metab 2008; 34: S3-S9.
29. Fauconnier J, Andersson DC, Zhang SJ, et al. Effects of palmitate on Ca(2+) handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes 2007; 56: 1136-1142. (Pubitemid 46525069)
30. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc Res 2008; 79: 279-286. (Pubitemid 351951616)
31. Dong F, Zhang X, Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension 2006; 47: 222-229. (Pubitemid 43189767)
32. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007; 101: 545-559. (Pubitemid 351325872)
33. Rahmouni K, Haynes WG. Endothelial effects of leptin: implications in health and diseases. Curr Diab Rep 2005; 5: 260-266. (Pubitemid 41269590)
34. Sivitz WI, Walsh S, Morgan D, Donohoue P, Haynes W, Leibel RL. Plasma leptin in diabetic and insulin-treated diabetic and normal rats. Metabolism 1998; 47: 584-591. (Pubitemid 28213120)
35. Gariono RF, Nath AK, D'Amico DJ, Lee T, Sierra-Honigmann MR. Elevation of vitreos leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci 2000; 41: 3576-3581. (Pubitemid 30774950)
36. Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J Mol Cell Cardiol 2000; 32: 1621-1629. (Pubitemid 30736119)
37. Zeidan A, Paylor B, Steinhoff KJ, et al. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3 kinase/protein kinase B-dependent pathways. J Pharmacol Exp Ther 2007; 322: 1110-1116. (Pubitemid 47295778)
38. Zeidan A, Javadov S, Chakrabarti S, Karmazyn M. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res 2008; 77: 64-72. (Pubitemid 351195148)
39. Xin X, Khan ZA, Chen S, Chakrabarti S. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 2004; 84: 1451-1459. (Pubitemid 39482162)
40. Xin X, Khan ZA, Chen S, Chakrabarti S. Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells. Diabetologia 2005; 48: 2428-2436. (Pubitemid 41618936)
41. Homsi ME, Ducroc R, Claustre J, et al. Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways. Am J Physiol Gastrointest Liver Physiol 2007; 293: 365-373.
42. Uchida Y, Ohba K, Ogawa A, Wada K, Yoshioka T, Muraki T. Protein kinase C mediates tumor necrosis factor-a-induced inhibition of obese gene expression and leptin secretion in brown adipocytes. Naunyn-Schmiedebergs Arch Pharmacol 1999; 360: 691-698. (Pubitemid 30012470)
43. Wakasaki H, Koya D, Schoen FJ, et al. Targeted overexpression of protein kinase C beta 2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 1997; 94: 9320-9325. (Pubitemid 27357827)
44. Valerio A, Dossena M, Bertolotti P, et al. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel- dependent transcription. Stroke 2008; 40: 610-617.
45. Issad T, Kuo M. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Endocrinol Metab 2008; 19: 380-389.
46. Fülöp N, Marchase RB, Chatham JC. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res 2007; 73: 288-297. (Pubitemid 44937687)